{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:27:32Z","timestamp":1784744852741,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the joint research program of the Research Center for GLOBAL and LOCAL Infectious Diseases, Oita University","award":["2024B11"],"award-info":[{"award-number":["2024B11"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0210125"],"award-info":[{"award-number":["JP23fk0210125"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24fk0210125"],"award-info":[{"award-number":["JP24fk0210125"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K20884"],"award-info":[{"award-number":["JP22K20884"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K11087"],"award-info":[{"award-number":["JP24K11087"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76532-5","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T14:01:54Z","timestamp":1729951314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circulating thrombospondin 2 as a predictor of hepatocellular carcinoma in hepatitis B patients undergoing nucleos(t)ide analog therapy"],"prefix":"10.1038","volume":"14","author":[{"given":"Taiki","family":"Okumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Iwadare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai P.","family":"Pydi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,26]]},"reference":[{"key":"76532_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.4254\/wjh.v7.i11.1541","volume":"7","author":"A Tawada","year":"2015","unstructured":"Tawada, A., Kanda, T. & Yokosuka, O. Current and future directions for treating hepatitis B virus infection. World J. Hepatol. 7, 1541\u20131552. https:\/\/doi.org\/10.4254\/wjh.v7.i11.1541 (2015).","journal-title":"World J. Hepatol."},{"key":"76532_CR2","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/hep.20956","volume":"43","author":"HJ Yim","year":"2006","unstructured":"Yim, H. J. & Lok, A. S. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatology 43, S173-181. https:\/\/doi.org\/10.1002\/hep.20956 (2006).","journal-title":"Hepatology"},{"key":"76532_CR3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem, D. & Prince, A. M. Hepatitis B virus infection\u2013Natural history and clinical consequences. N. Engl. J. Med. 350, 1118\u20131129. https:\/\/doi.org\/10.1056\/NEJMra031087 (2004).","journal-title":"N. Engl. J. Med."},{"key":"76532_CR4","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. Electronic address, e. e. e. & European Association for the Study of the, L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 67, 370-398, https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021 (2017).","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"76532_CR5","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.23785","volume":"52","author":"TT Chang","year":"2010","unstructured":"Chang, T. T. et al. Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 52, 886\u2013893. https:\/\/doi.org\/10.1002\/hep.23785 (2010).","journal-title":"Hepatology"},{"key":"76532_CR6","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/hep.26301","volume":"58","author":"GL Wong","year":"2013","unstructured":"Wong, G. L. et al. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis. Hepatology 58, 1537\u20131547. https:\/\/doi.org\/10.1002\/hep.26301 (2013).","journal-title":"Hepatology"},{"key":"76532_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12885-022-09413-7","volume":"22","author":"ZH Huang","year":"2022","unstructured":"Huang, Z. H. et al. Risk of hepatocellular carcinoma in antiviral treatment-naive chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: A network meta-analysis. BMC Cancer 22, 287. https:\/\/doi.org\/10.1186\/s12885-022-09413-7 (2022).","journal-title":"BMC Cancer"},{"key":"76532_CR8","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.bbagen.2014.01.013","volume":"2396\u20132402","author":"NE Calabro","year":"1840","unstructured":"Calabro, N. E., Kristofik, N. J. & Kyriakides, T. R. Thrombospondin-2 and extracellular matrix assembly. Biochim. Biophys. Acta 2396\u20132402, 2014. https:\/\/doi.org\/10.1016\/j.bbagen.2014.01.013 (1840).","journal-title":"Biochim. Biophys. Acta"},{"key":"76532_CR9","doi-asserted-by":"publisher","first-page":"18900","DOI":"10.1038\/s41598-022-23357-9","volume":"12","author":"T Iwadare","year":"2022","unstructured":"Iwadare, T. et al. Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients. Sci Rep 12, 18900. https:\/\/doi.org\/10.1038\/s41598-022-23357-9 (2022).","journal-title":"Sci Rep"},{"key":"76532_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/liv.14776","volume":"41","author":"T Kimura","year":"2021","unstructured":"Kimura, T. et al. Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD. Liver Int 41, 505\u2013514. https:\/\/doi.org\/10.1111\/liv.14776 (2021).","journal-title":"Liver Int"},{"key":"76532_CR11","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/hep.31995","volume":"74","author":"K Kozumi","year":"2021","unstructured":"Kozumi, K. et al. Transcriptomics identify thrombospondin-2 as a biomarker for NASH and advanced liver fibrosis. Hepatology 74, 2452\u20132466. https:\/\/doi.org\/10.1002\/hep.31995 (2021).","journal-title":"Hepatology"},{"key":"76532_CR12","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2337\/dc21-0131","volume":"44","author":"CH Lee","year":"2021","unstructured":"Lee, C. H. et al. Circulating thrombospondin-2 as a novel fibrosis biomarker of nonalcoholic fatty liver disease in type 2 diabetes. Diabetes Care 44, 2089\u20132097. https:\/\/doi.org\/10.2337\/dc21-0131 (2021).","journal-title":"Diabetes Care"},{"key":"76532_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000466","author":"AG Singal","year":"2023","unstructured":"Singal, A. G. et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology https:\/\/doi.org\/10.1097\/hep.0000000000000466 (2023).","journal-title":"Hepatology"},{"key":"76532_CR14","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3748\/wjg.v24.i13.1440","volume":"24","author":"T Kimura","year":"2018","unstructured":"Kimura, T. et al. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis. World J. Gastroenterol. 24, 1440\u20131450. https:\/\/doi.org\/10.3748\/wjg.v24.i13.1440 (2018).","journal-title":"World J. Gastroenterol."},{"key":"76532_CR15","doi-asserted-by":"crossref","unstructured":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 20, 15\u201320 (1994).","DOI":"10.1016\/0270-9139(94)90128-7"},{"key":"76532_CR16","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/nejm199306243282501","volume":"328","author":"H Tsukuma","year":"1993","unstructured":"Tsukuma, H. et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 328, 1797\u20131801. https:\/\/doi.org\/10.1056\/nejm199306243282501 (1993).","journal-title":"N. Engl. J. Med."},{"key":"76532_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jhep.2016.09.013","volume":"66","author":"M Chayanupatkul","year":"2017","unstructured":"Chayanupatkul, M. et al. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. J. Hepatol. 66, 355\u2013362. https:\/\/doi.org\/10.1016\/j.jhep.2016.09.013 (2017).","journal-title":"J. Hepatol."},{"key":"76532_CR18","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","volume":"142","author":"TC Tseng","year":"2012","unstructured":"Tseng, T. C. et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology 142, 1140\u20131144. https:\/\/doi.org\/10.1053\/j.gastro.2012.02.007 (2012).","journal-title":"Gastroenterology"},{"key":"76532_CR19","doi-asserted-by":"publisher","first-page":"a009712","DOI":"10.1101\/cshperspect.a009712","volume":"3","author":"JC Adams","year":"2011","unstructured":"Adams, J. C. & Lawler, J. The thrombospondins. Cold Spring Harb. Perspect Biol. 3, a009712. https:\/\/doi.org\/10.1101\/cshperspect.a009712 (2011).","journal-title":"Cold Spring Harb. Perspect Biol."},{"key":"76532_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1172\/JCI12749","volume":"107","author":"P Bornstein","year":"2001","unstructured":"Bornstein, P. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107, 929\u2013934. https:\/\/doi.org\/10.1172\/JCI12749 (2001).","journal-title":"J. Clin. Invest."},{"key":"76532_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/liv.15792","volume":"44","author":"T Kimura","year":"2024","unstructured":"Kimura, T. et al. Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease. Liver Int. 44, 483\u2013496. https:\/\/doi.org\/10.1111\/liv.15792 (2024).","journal-title":"Liver Int."},{"key":"76532_CR22","doi-asserted-by":"publisher","first-page":"965548","DOI":"10.3389\/fimmu.2022.965548","volume":"13","author":"E Tourkochristou","year":"2022","unstructured":"Tourkochristou, E., Assimakopoulos, S. F., Thomopoulos, K., Marangos, M. & Triantos, C. NAFLD and HBV interplay: Related mechanisms underlying liver disease progression. Front Immunol 13, 965548. https:\/\/doi.org\/10.3389\/fimmu.2022.965548 (2022).","journal-title":"Front Immunol"},{"key":"76532_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.14218\/JCTH.2020.00095","volume":"9","author":"C Saraceni","year":"2021","unstructured":"Saraceni, C. & Birk, J. A review of hepatitis B virus and hepatitis C virus immunopathogenesis. J. Clin. Transl. Hepatol. 9, 409\u2013418. https:\/\/doi.org\/10.14218\/JCTH.2020.00095 (2021).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"76532_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12079-009-0077-z","volume":"3","author":"TR Kyriakides","year":"2009","unstructured":"Kyriakides, T. R. & Maclauchlan, S. The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J. Cell Commun. Signal 3, 215\u2013225. https:\/\/doi.org\/10.1007\/s12079-009-0077-z (2009).","journal-title":"J. Cell Commun. Signal"},{"key":"76532_CR25","doi-asserted-by":"publisher","first-page":"e13067","DOI":"10.1002\/jgh3.13067","volume":"8","author":"N Tamaki","year":"2024","unstructured":"Tamaki, N. et al. Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B. JGH Open 8, e13067. https:\/\/doi.org\/10.1002\/jgh3.13067 (2024).","journal-title":"JGH Open"},{"key":"76532_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.14042","author":"Y Hiyama","year":"2024","unstructured":"Hiyama, Y. et al. Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs. Hepatol Res https:\/\/doi.org\/10.1111\/hepr.14042 (2024).","journal-title":"Hepatol Res"},{"key":"76532_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/hepr.12712","volume":"47","author":"Y Ichikawa","year":"2017","unstructured":"Ichikawa, Y. et al. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Hepatol Res 47, 226\u2013233. https:\/\/doi.org\/10.1111\/hepr.12712 (2017).","journal-title":"Hepatol Res"},{"key":"76532_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/hep.27654","volume":"61","author":"B Suh","year":"2015","unstructured":"Suh, B. et al. High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatology 61, 1261\u20131268. https:\/\/doi.org\/10.1002\/hep.27654 (2015).","journal-title":"Hepatology"},{"key":"76532_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12935-022-02622-x","volume":"22","author":"X Liao","year":"2022","unstructured":"Liao, X., Wang, W., Yu, B. & Tan, S. Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach adenocarcinomas: An integrative pan-cancer analysis. Cancer Cell Int 22, 213. https:\/\/doi.org\/10.1186\/s12935-022-02622-x (2022).","journal-title":"Cancer Cell Int"},{"key":"76532_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12094-021-02685-8","volume":"24","author":"J Byrling","year":"2022","unstructured":"Byrling, J., Hilmersson, K. S., Ansari, D., Andersson, R. & Andersson, B. Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma. Clin. Transl. Oncol. 24, 297\u2013304. https:\/\/doi.org\/10.1007\/s12094-021-02685-8 (2022).","journal-title":"Clin. Transl. Oncol."},{"key":"76532_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020463","author":"T Matsumae","year":"2023","unstructured":"Matsumae, T. et al. Thrombospondin-2 as a predictive biomarker for hepatocellular carcinoma after hepatitis C virus elimination by direct-acting antiviral. Cancers https:\/\/doi.org\/10.3390\/cancers15020463 (2023).","journal-title":"Cancers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76532-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76532-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76532-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T14:04:40Z","timestamp":1729951480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76532-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76532"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76532-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3615390\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,26]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25584"}}